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SUMo promotes longevity 
and maintains mitochondrial 
homeostasis during ageing 
in Caenorhabditis elegans
Andrea princz1,2, Federico Pelisch3 & nektarios tavernarakis2,4*
The insulin/IGF signalling pathway impacts lifespan across distant taxa, by controlling the activity of 
nodal transcription factors. in the nematode Caenorhabditis elegans, the transcription regulators DAF-
16/FOXO and SKN-1/Nrf function to promote longevity under conditions of low insulin/IGF signalling 
and stress. The activity and subcellular localization of both DAF-16 and SKN-1 is further modulated by 
specific posttranslational modifications, such as phosphorylation and ubiquitination. Here, we show 
that ageing elicits a marked increase of SUMo levels in C. elegans. In turn, SUMO fine-tunes DAF-16 
and SKN-1 activity in specific C. elegans somatic tissues, to enhance stress resistance. SUMOylation 
of DAF-16 modulates mitochondrial homeostasis by interfering with mitochondrial dynamics and 
mitophagy. Our findings reveal that SUMO is an important determinant of lifespan, and provide novel 
insight, relevant to the complexity of the signalling mechanisms that influence gene expression to 
govern organismal survival in metazoans.
Organismal homeostasis is relentlessly challenged by various external and internal stressors. Over the course of 
life, homeostasis gradually declines and finally collapses, leading to death. Studies in organisms ranging from 
microbes to humans have culminated in the identification of multiple hallmarks of the ageing process and 
numerous regulatory factors that influence  lifespan1,2. Amongst these, the insulin/IGF-1 pathway has a major 
role in lifespan  determination3,4; and is evolutionarily conserved from worms to  mammals5. In the nematode 
Caenorhabditis elegans, it entails the activation of insulin receptor DAF-2 (dauer formation abnormal), by insulin-
like peptides. The activated receptor triggers a series of phosphorylation events in the cytoplasm, including the 
phosphorylation of the FOXO transcription factor, DAF-16. The phosphorylated form of DAF-16 is retained in 
the cytoplasm. Under stress conditions (heat shock, starvation, oxidative stress) DAF-16 is no longer phosphoryl-
ated and translocates to the nucleus, where it activates the transcription of genes responsible for development, 
longevity, re-wiring of metabolism, and stress  responses6,7. Importantly, other stress responsive transcription 
factors such as SKN-1, function together with DAF-16. SKN-1 (skinhead) is the orthologue of the mammalian 
NRF2 (Nuclear factor erythroid 2-related factor 2) and has a main role in oxidative stress  response8.
The functional decline of mitochondria during ageing is another major determinant of lifespan. The ageing 
process brings about the accumulation of dysfunctional mitochondria, which exhibit increased ROS produc-
tion, accrual of mitochondrial DNA, and less efficient ATP  production1. In addition, mitochondrial dynamics 
is also altered over the course of  lifespan9. The proper balance of mitochondrial biogenesis and mitochondrial 
clearance by organelle-specific autophagy (mitophagy) is a prerequisite of healthy ageing. DAF-16 and SKN-1 
are key regulators of these two  processes10. The activity of these transcription factors is modulated by many tar-
geted posttranslational protein modifications, including phosphorylation, methylation, and  ubiquitination11–13. 
We sought to investigate whether other modes of posttranslational modification influence the activity of these 
nodal transcription factors, under normal and stress conditions.
SUMOylation, the attachment of a small ubiquitin like modifier (SUMO) to a target protein, is a posttransla-
tional modification that plays pivotal roles in fundamental cellular processes including DNA damage responses, 
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mitochondrial dynamics, development and senescence, among  others14,15. In close analogy to ubiquitination, 
regulatory SUMOylation requires a heterodimeric E1 activating enzyme, an E2 conjugation enzyme, an E3 SUMO 
ligase and a SUMO protease. The C. elegans genome encodes a sole SUMO gene, smo-1, which makes it an expe-
dient model organism to dissect its diverse functions. SUMOylation has been mainly studied in the context of 
development in C. elegans, and has been implicated in embryonic, vulval and muscle development, and in DNA 
damage  responses16–27. Recently, SUMOylation of a specific RNA binding protein (CAR-1) in the germline has 
been linked to organismal  ageing28. Notably, the level of SUMO1 modified proteins has been shown to progres-
sively increase during ageing in blood plasma and cortical lysates of  mice29. However, a causative relationship 
between SUMOylation and ageing has not been established.
Here, we uncover a direct link between SUMO and the regulation of ageing, in C. elegans. Perturbation of 
SUMO levels causes alterations in lifespan and mitochondrial homeostasis in a DAF-16/FOXO and SKN-1/NRF2 
dependent manner. Reduced smo-1 expression leads to shortened lifespan, coupled with impaired mitochondrial 
ATP and ROS production, mitophagy defects and over-activation of stress response genes. In addition, we dem-
onstrate for the first time that DAF-16 is SUMOylated, and that this modification represses the transcriptional 
activity of DAF-16.
Materials and methods
C. elegans strains and genetics. We followed standard procedures for maintenance of C. elegans 
strains and transgenic  lines30. Animals were grown at 20  °C unless noted otherwise. The following strains 
were used for this study: N2: wild type Bristol isolate, CB1370: daf-2(e1370)III, MQ887: isp-1(qm150)IV, 
CF1038: daf-16(mu86)I, KX15: ife-2(ok306)X, SJ4143: N2;Is[pges-1mtGFP], CL2166: N2;Is[pgst-4GFP], CF1553: 
N2;Is[psod-3GFP], TJ356: N2;Is[pdaf-16DAF-16a/b::GFP;rol-6(su1006)], FGP14: unc-119(ed3); fgpIs35[unc-
119(+);psmo-1::6xHis::smo-1::smo-1 3′ UTR ], VP303: rde-1(ne219)V;kbIs7[pnhx-2::rde-1;rol-6(su1006)], NR350: 
rde-1(ne219)V; kzIs20[phlh-1::rde-1;psur-5::NLS::GFP], NR222: rde-1(ne219)V;kzIs9[plin-26::NLS::GFP;plin-26::rde-
1;rol-6(su1006)], TU3401: sid-1(pk3321)V;uIs69[pmyo-2::mCherry;punc-119::sid-1], NL2099: rrf-3(pk1426)II, JRIS1: 
N2;  Is[prpl-17HyPer]..
Molecular cloning. To create a  psmo-1DsRed::SMO-1 construct, we utilized the pPD95.77(DsRed) con-
struct, previously generated in the lab. Briefly, GFP was excised from pPD95.77 (GFP) vector using the AgeI/
EcoRI restriction enzymes, and was replaced with the fragment coding DsRed, isolated from  pcol-12DsRed31. We 
amplified the smo-1 ORF from C. elegans genomic DNA, using the following primer pair: 5′-GAA TTC CAA 
CAT GGC CGA TGA TGC AG-3′ and 5′-GGA TCC CGT TTA TAG CGG GAG TCT C-3′ and the 560 bp product was 
first subcloned into pCRII-TOPO vector (Invitrogen). Using the restriction enzyme EcoRI, the fragment was 
excised and inserted into pPD95.77 (DsRed) and was sequenced to check for possible mutations and orien-
tation. The correct construct was introduced to unc-119(ed3) worms, together with  pRH2132, using biolistic 
transformation. To generate the  pvha-6SMO-1 construct, we amplified the smo-1 ORF from C. elegans genomic 
DNA, using the following primer pair: 5′-GTT TCA GAG ACT CCC GCT ATA AAC -3′ and 5′-GCT AGC CGA AGA 
GTT TAT TTG TAA G-3′ and the 570 bp product was subcloned into pCRII-TOPO vector. Using the restriction 
enzymes BamHI/NheI, the fragment was inserted in pPD96.52 vector, containing the myo-3 promoter. The 
promoter was removed, using the HindIII/XbaI restriction enzymes and the 950 bp coding sequence of vha-6 
promoter was inserted from pCRII-TOPO. To amplify the vha-6 promoter from C. elegans genomic DNA, we 
used the following primer pair: 5′-GAG AAG ATG TGA TGA GAT GGA GAG AAAG-3′ and 5′-TGA GCA CTT TAC 
AGT TCT TGT TGA TTTG-3′. The construct, together with the pRH21 plasmid, was introduced to unc-119(ed3) 
worms, using biolistic transformation. To generate the  prab-3SMO-1 construct, we amplified the smo-1 ORF from 
C. elegans genomic DNA, using the following primer pair: 5′-CCC GGG GTT TCA GAG ACT C-3′ and 5′-GGT 
ACC CGA AGA GTT TAT TTG TAA G-3′ and the 580 bp product was subcloned into pCRII-TOPO vector. We 
inserted the Xma/KpnI fragment in pPD95.77, containing the rab-3 promoter. The construct and the pRH21 
plasmid were introduced to unc-119(ed3) worms, using biolistic transformation. For the generation of smo-1, 
ubc-9 , ulp-1, ulp-2, ulp-4 and ulp-5 RNAi construct, the following primer pairs were used: 5′-TAA ACG ATG 
GCC GAT GAT GC-3′ and 5′-GGA TCC CGA AAG AGT TTA TTT GTA AG-3′, 5′-ATG TCG GGA ATT GCT GCA 
GG-3′ and 5′-GTC CAG AAG CAA ATG CTC GAG TAG -3′, 5′-CCA CAG TTG TTA CAG AAC AAG-3′ and 5′-GGA 
TCC CAC ATT AGT TTC TCT GCT TC-3′, 5′-ATG AGT GAT TCA ACT CAA ATG GAG G-3′ and 5′-CAT ACA GCA 
GTT GCC ACA AACG-3′, 5′-ATG GAA GTG TCA ACG TCT TAC TGT ACG-3′ and 5′-GAT TTT TGC TGT CTC 
CAG GAG AAG -3′, 5′-ATG CCT CAT CCT AAG CTC ACTCC-3′ and 5′-GCC TGG TTC ATT CAA AAA AAT ACA 
G-3′, respectively. The resulted fragments were cloned into the vector pL4440 and the constructs were trans-
formed into HT115 (DE3) Escherichia coli strain, which is defective for RNase III. Bacteria carrying the pL4440 
empty vector alone were used for control experiments. RNAi constructs against daf-2, eat-3, daf-16, skn-1, drp-1, 
fzo-1 have been described  previously10,33. Double RNAi against skn-1 and smo-1 was constructed by digesting 
the skn-1(RNAi) and smo-1(RNAi) plasmids with BamHI restriction enzyme and ligating the smo-1 fragment 
(~ 1000 bp) into skn-1(RNAi) plasmid, treated with Alkaline Phosphatase, Calf Intestinal (CIP, New England 
Biolabs).
Epifluorescence and confocal microscopy. Transgenic worms were placed in a drop of 10 mM lev-
amisole on a microscope slide and sealed with a cover slip. Images were taken with a Zeiss AxioImager Z2 
epifluorescence microscope. At least 25 worms were imaged and quantified per condition; each experiment was 
repeated at least three times. Mean fluorescence intensity was measured using the software Image J. The nuclear/
cytoplasmic ratio of  pdaf-16DAF-16::GFP was measured as follows: we measured the mean fluorescence intensity 
of a nucleus and the intensity of the same selection area of the corresponding cytoplasm. These two numbers 
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were divided to get the ratio. For confocal microscopy, animals were immobilized on a 5% agarose pad, in a 5 μl 
drop of Nanobeads (Nanobeads NIST Traceable Particle Size Standard 100 nm, Polysciences). Images were taken 
with an LSM710 Zeiss confocal microscope, Axio-observer Z1.
Western blot analysis. For the analysis of SUMO conjugated proteins during ageing, synchronized ani-
mals were collected in M9 buffer and after a short spin, the buffer was exchanged to the lysis buffer (50 mM 
Tris–HCl pH: 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1 mM PMSF, 30 mM NEM) supplemented 
with protease inhibitor cocktail (cOmplete mini protease inhibitors cocktail tablets—ROCHE) just before use. 
Animals were frozen at − 80 °C and then boiled at 95 °C together with 1X Laemmli sample buffer (70 mM SDS, 
1.5 mM bromophenol blue, 0.8% glycerol, 10 mM Tris–HCl pH: 6.8, 100 mM DTT). The lysates were spun down 
at 4 °C, then loaded and separated by 4–12% Bis–Tris gel and transferred to PVDF membrane (Amersham-GE 
Healthcare). The membrane was blocked using 5% non-fat milk for 1 h and then incubated overnight with anti-
SUMO  antibody34 (Developmental Studies Hybridoma Bank (DSHB) Cat# SUMO 6F2, RRID:AB_2618393, 
1:250) and with anti-α-tubulin antibody (DSHB Cat# AA4.3, RRID:AB_579793, 1:5000) in 5% non-fat milk at 
4 °C. The next day the membrane was washed with 1XPBS-T (0.1% Tween 20) and incubated with horseradish 
peroxidase-conjugated secondary antibody for 1 h at room temperature. After washes with 1XPBS-T, the mem-
brane was developed by chemiluminescence (Supersignal chemiluminescent substrate pico and femto, Thermo 
Fisher Scientific).
For the analysis of SUMO conjugated proteins upon smo-1(RNAi) and SMO-1 overexpression (FGP14 strain), 
animals were washed and collected from two plates in M9 buffer with 0.1% Triton-X 100. Animals were washed 
one time with M9 buffer with 0.1% Triton-X 100 and transferred to a new tube. 200 μl of 40% trichloroacetic acid 
(TCA) (Sigma-Aldrich) and 300 μl glass beads (Sigma-Aldrich) were added to each sample. Samples were lysed 
by using a Beadbeater (Biospec), for 3 min (1 min on–1 min off) in a cold room. Lysates were transferred to a 
new tube and the beads were washed with 5% TCA and mixed with the lysates. Samples then were centrifuged for 
15 min at 13,000 rpm at 4 °C. The pellet was washed three times with 500 μl chilled acetone. Pellets were dried at 
room temperature and resuspended in 100 μl 1X Sample Reducing Agent (Thermo Fisher Scientific). Following 
a 5 min incubation at 70 °C, samples were sonicated 2× for 10 s (12% amplitude). Samples were incubated again 
at 70 °C and then centrifuged for 10 min at 11,000 rpm. Samples were transferred to a new tube and loaded onto 
a 4–12% Bis–Tris gel for separation, transferred to a nitrocellulose membrane (Amersham-GE Healthcare). The 
membrane was blocked in a blocking solution (Invitrogen) for 1 h and then incubated overnight with anti-SUMO 
antibody (sheep)35 (1:1000) and with anti-α-tubulin antibody (DSHB Cat# AA4.3, RRID:AB_579793, 1:5000) 
in 3% BSA at 4 °C. The next day the membrane was washed with 1XPBS-T (0.1% Tween 20) and incubated with 
AlexaFluor 647 secondary antibody for 1 h at room temperature. After washes with 1XPBS-T, the membrane 
was analyzed with Amersham Typhoon Biomolecular Imager (GE Healthcare).
Mitochondria isolation. Age matched animals were collected in M9 buffer, and incubated at 4 °C with 
rotation in the presence of 10 mM DTT. To remove the DTT from the sample, three washes were performed 
with M9. Worms were homogenized in incubation buffer [50 mM Tris–HCl pH:7.4, 210 mM mannitol, 70 mM 
sucrose, 0.1 mM EDTA, 2 mM PMSF, cOmplete mini protease inhibitors cocktail (ROCHE)] with 100 strokes 
in a 3 ml Potter–Elvehjem homogenizer with PTFE pestle and glass tube (Sigma-Aldrich). The lysate was centri-
fuged at 200g for 1 min. The pellet was subjected to another round of homogenization. The lysate was combined 
with the supernatant from the previous centrifugation step, and they were centrifuged together for 1 min at 200g. 
The supernatant was centrifuged again at 12,000g for 5 min. We kept the supernatant as the cytoplasmic frac-
tion and resuspended the pellet/mitochondrial fraction in incubation buffer. Samples were analysed on 4–12% 
SDS-PAGE gradient gels with anti-SUMO (DSHB Cat# SUMO 6F2, RRID:AB_2618393), anti-MTCO1 (Abcam 
[1D6E1A8] (ab14705)) and anti-α-tubulin (DSHB Cat# AA4.3, RRID:AB_579793).
DAF-16 and SKN-1 purification. We codon optimized the sequence of isoform “a” of DAF-16 (UniProt 
number: O16850) and isoform “c” of SKN-1 (UniProt number: P34707) and inserted into a vector suitable for 
bacterial expression, pHis-TEV-30a36. This vector also contains an N terminal 6xHis-MBP tag and a TEV cleav-
age site. The construct was transformed to BL21 Rosetta E. coli strain for protein expression. Bacterial cultures 
were grown at 37 °C until  OD600 = 0.8, then cooled down and induced with 1 mM IPTG at 20 °C for 4 h for DAF-
16 expression and with 0.1 mM IPTG at 37 °C for 4 h for SKN-1 expression. The cells were pelleted by centrifu-
gation (4500 rpm, 30 min, 4 °C) and resuspended in 50 ml lysis buffer (50 mM Tris–HCl, 0.5 M NaCl, 10 mM 
imidazole, pH 7.5) supplemented with 0.5 mM TCEP and cOmplete mini protease inhibitors cocktail tablets 
– ROCHE. Cells were lysed by sonication (Digital Sonifier, Branson) for 5X 20 s pulses at 50% amplitude with 
20 s cooling period between pulses. Cell lysate was centrifuged (15,000 rpm, 45 min, 4 °C) to clear the sample 
from any insoluble material and supernatant was loaded onto a 2 ml Ni–NTA column (Qiagen) pre-equilibrated 
with lysis buffer. After sample binding, the column was washed with ten column volume of lysis buffer and with 
ten column volume of lysis buffer containing 30 mM imidazole. The protein was eluted from the column with 
elution buffer (50 mM Tris–HCl, 150 mM NaCl, 150 mM imidazole, 0.5 mM TCEP). DAF-16 was further puri-
fied by size exclusion chromatography with Superose 6 Increase 10/300 column (GE Healthcare). Purified and 
concentrated protein was aliquoted and stored at − 80 °C.
in vitro SUMoylation assays. Conjugation assays contained 50  mM Tris–HCl, 0.5  mM TCEP, 5  mM 
 MgCl2, 2 mM ATP, 5 μg SUMO, 0.5 μg SUMO-Alexa Fluor 680, 60 ng SAE1/SAE2 (SUMO E1), 5 or 20 ng UBC-
9, 10, 50 or 100 ng GEI-17 and 5 μg DAF-16, SKN-1 or MBP. Reactions were incubated at 30 °C for 4 h and they 
were run parallel on 4–12% Bis–Tris (better visualization of free SUMO) and 3–8% Tris–Acetate gels (better 
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visualization of SUMO modified proteins). Gels were analyzed by Coomassie staining and Amersham Typhoon 
Biomolecular Imager (GE Healthcare)35.
Mitochondrial imaging. For TMRE (tetramethylrhodamine, ethyl ester) (Sigma) staining, age-matched 
animals were placed overnight on an RNAi plate containing 150 nM TMRE and the next morning placed in a 
10 mM levamisole drop on a microscope slide, sealed with a cover slip. Images were taken with a Zeiss Axio-
Imager Z2 epifluorescence microscope. For mitochondrial ROS staining, synchronized animals were placed on 
RNAi plates containing 150 nM MitoTracker Red CMXROS (Thermo Fisher Scientific) overnight and the next 
morning were mounted on microscope slides in a 10 mM levamisole drop, sealed with a cover slip to assess mito-
chondrial ROS production. Images were taken with a Zeiss AxioImager Z2 epifluorescence microscope. Images 
were quantified using the software Image J. For paraquat treated TMRE staining, age-matched animals were 
placed on RNAi plates containing 4 mM paraquat for 1 day, and the next day were transferred to a fresh RNAi 
plate containing 4 mM paraquat and 150 nM TMRE. The next morning the animals were placed on microscope 
slides in a 10 mM levamisole drop, sealed with a cover slip. Images were taken with a Zeiss AxioImager Z2 epif-
luorescence microscope. Images were quantified using the software Image J. For monitoring mitophagy we used 
the previously described mitochondrial targeted Rosella biosensor in body wall muscle cells of the  animals10, 
with a minor modification. We created a new transgenic line with biolistic transformation and fed these animals 
with the test RNAi constructs. Animals were mounted on 5% agarose pads in a 10 mM levamisole drop and 
sealed with a cover slip. Images were taken with an Invitrogen EVOS FL Auto 2 Cell Imaging System. Images 
were quantified using the software Image J.
Messenger RNA quantification. Total RNA was extracted from worms, using Trizol (Sigma). cDNA 
was synthesized using the iScript kit (BioRad). Quantitative Real Time PCR was performed using a Bio-Rad 
CFX96 Real-Time PCR system, and was repeated three times. The following primer pairs were used to quan-
tify the expression of genes: for ges-1: 5′-TCG CCA AGA GGT ATG CTT CAC AAG -3′ and 5′-TGC TGC TCC TGC 
ACT GTA TCCC-3′, for gst-4: 5′-GGC AAG AAA ATT TGG ACT C-3′ and 5′-GCC AAG AAA TCA TCA CGG GC-3′, 
for sod-3: 5′-ATT GCT CTC CAA CCA GCG C-3′ and 5′-GGA ACC GAA GTC GCG CTT AA-3′, for smo-1: 5′-AAG 
ATC AAG GTC GTT GGA CAG GAC -3′ and 5′-CTA GAA TCC GCC CAG CTG CT-3′.
Atp measurements. To quantify intracellular ATP levels, we followed the protocol described  here37. In 
short, 100 age matched animals were collected in 50 µl of M9 buffer and frozen at − 80 °C. Frozen worms were 
boiled at 95 °C for 15 min. After a 10 min centrifugation step at 14,000 rpm at 4 °C, the supernatant was trans-
ferred to a fresh tube and diluted tenfold before measurement. ATP content was determined by using the Roche 
ATP bioluminescent assay kit HSII (Roche Applied Science) and a TD-20/20 luminometer (TurnerDesigns). 
ATP levels were normalized to total protein content.
oxygen consumption rate measurement. To determine oxygen consumption rates, we followed a pre-
viously described  protocol38. In short, 4-day-old adult animals were collected in 1 ml M9, and transferred to the 
chamber of Oxygraph (Hansatech Instruments). Measurements were performed for 15 min at 20 °C. The oxygen 
consumption rate was obtained by the slope of the straight portion of the plot. The animals were recovered after 
measurement and were subjected to sonication and protein determination. The oxygen consumption rates were 
normalized to total protein content.
Mitochondrial DNA quantification. mtDNA was quantified using quantitative real time PCR as 
described  previously39. 50 worms were collected per condition, lysed and diluted tenfold before performing the 
PCR reaction. The following primer set was used for mtDNA (mito-1): 5′-GTT TAT GCT GCT GTA GCG TG-3′ 
and 5′-CTG TTA AAG CAA GTG GAC GAG-3′. The results were normalized to genomic DNA using the following 
primers specific for ama-1: 5′-TGG AAC TCT GGA GTC ACA CC-3′ and 5′-CAT CCT CCT TCA TTG AAC GG-3′. 
Quantitative PCR was performed using a Bio-Rad CFX96 Real-Time PCR system, and was repeated three times.
Lifespan analysis. Experiments were carried out at 20 °C, unless noted otherwise. Animals were synchro-
nized by placing 7–8 gravid adults on control RNAi plates for overnight egg laying and they were removed the 
next morning. L4 larvae were placed on experimental plates (containing 2 mM IPTG and seeded with HT115 
(DE3) bacteria comprising the control vector (pL4440) or the test RNAi construct) and they were transferred 
to a fresh plate every 2–3 days. Animals were scored for survival with movement provoking touch every second 
day. Those who crawled out of the plate or died due to internal egg-hatching were considered censored and 
incorporated into the dataset as such. Each lifespan assay was repeated at least two times and figures represent 
typical assays. Lifespan assays on NAC (N-acetyl cysteine) plates (10 mM final concentration) were performed 
only one time. Statistical analysis was performed using the Prism software package (version 7; GraphPad Soft-
ware; https ://www.graph pad.com), and the product-limit method of Kaplan and Meier.
Survival assays. For oxidative stress assays we grew synchronized animals until day 6 of adulthood on con-
trol or smo-1(RNAi) plates. At day 6 animals were transferred to control or smo-1(RNAi) plates containing para-
quat (methyl viologen dichloride hydrate, Sigma) in 2 mM final concentration. Additionally, bacteria were killed 
with UV before adding paraquat on the plates in order to prevent interference arising from bacterial metabolism.
For acute heat stress survival the animals were grown until day 4 of adulthood on control or smo-1(RNAi) 
plates at 20 °C. At day 4 of adulthood, animals were subjected to 37 °C for 2 h and then placed back to 20 °C. In 
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both stress conditions animals were scored for survival with movement provoking touch every day. Those who 
crawled out of the plate or died due to internal egg-hatching were considered censored and incorporated into 
the dataset as such. Each stress survival assay was repeated at least two times and figures represent typical assays. 
Statistical analysis was performed using the Prism software package (version 7; GraphPad Software; https ://www.
graph pad.com), and the product-limit method of Kaplan and Meier.
Statistical analysis. Statistical analyses were carried out using the Prism software package (version 7; 
GraphPad Software; https ://www.graph pad.com) and the Microsoft Office 2010 Excel software package (Micro-
soft Corporation, Redmond, WA, USA). Mean values were compared using unpaired t-tests or one-way ANOVA.
Results
SUMoylation modulates ageing in C. elegans. To examine SUMOylation over the course of age-
ing in C. elegans, we performed Western blot analysis, using age matched, wild type animals. We find that the 
amount of SUMO conjugated proteins peaks at day 4 of adulthood in C. elegans (Fig. 1A). To assess SUMO 
expression, we generated transgenic animals, expressing a full-length, DsRed-tagged SMO-1 reporter fusion 
 (psmo-1DsRed::SMO-1; Fig. 1B). We observed nuclear localization of SUMO in all tissues (e.g. neurons, seam 
cells, intestine and muscles; Fig. 1B). SMO-1 expression increases during ageing and upon a temperature shift 
to 25 °C (Fig. 1C). Thus, SMO-1 expression is progressively increasing with age and under mild thermal stress, 
in C. elegans.
SUMOylation is essential during  development40. Consequently, mutation of smo-1 causes embryonic 
 lethality41,42. To examine the physiological significance of SUMO accumulation during ageing, we reduced smo-
1 expression post-developmentally, at the end of the L4 larval stage by RNAi (Fig. S1A). We observed significant 
reduction of animal lifespan (Fig. 2A). By contrast, downregulation of the 4 SUMO proteases (ubiquitin-like 
proteases), encoded in the C. elegans genome (ulp-1-2, ulp-4-5), did not alter the lifespan of wild type animals 
(Fig. S1B,C), under normal conditions. However, reduced expression of ulp-1 resulted in a prolonged lifespan 
at 25 °C (Fig. S1D). Importantly, smo-1 overexpression extended lifespan (FGP14 strain, Pelisch and Hay, 2016; 
 psmo-1::6xHis::smo-1::smo-1 3′ UTR; Figs. S1A, 2B). These findings indicate that SUMO is a modulator of ageing 
in C. elegans.
Previous studies have established the prominent contribution of specific tissues in the control of the age-
ing  process43. To examine whether SUMO promotes longevity in a tissue specific manner, we targeted smo-1 
expression in different tissues by RNAi. We utilized transgenic strains carrying a mutation in rde-1 gene (RNAi 
defective), which encodes an Argonaute protein family member that is required for RNA  interference44. A wild 
type version of rde-1 is then re-introduced to the animals in a tissue specific manner, restoring RNAi capacity 
in that tissue. Using this approach, we assessed the effects of SUMO downregulation in the intestine (VP303 
strain), hypodermis (NR222 strain) and muscles (NR350 strain). Only intestine specific smo-1(RNAi) resulted in 
shorter lifespan, while knockdown of smo-1 in hypodermal and muscle tissues had no effect (Fig. 2C, Fig.S1E,F). 
We also investigated the consequences of neuron-specific SUMO deficiency. The nervous system of C. elegans is 
mostly resistant to RNAi, but specific neurons (amphids and phasmids) are  susceptible45. To probe neuron spe-
cific SUMO depletion, we used a strain (TU3401), which carries a mutation in sid-1 (systemic RNA interference 
Figure 1.  SUMO levels are increasing during ageing. (A) Western blot analysis of SUMO protein levels in day 
1, 4 and 8 wild type lysates (n = 500 worms/sample, N = 4, day 1 vs day 4: p = 0.103, day 1 vs day 8: p = 0.119). 
Protein levels were normalized to α-tubulin. Error bars, S.E.M. (B)  psmo-1DsRed::SMO-1 expression pattern, 
scale bar: 40 μm. The image was acquired using a × 20 objective lens. (C) The expression of  psmo-1DsRed::SMO-1 
is increasing during ageing and when the animals are grown at 25 °C. (n = 50, *p < 0.05, **p < 0.01, ***p < 0.001, 
unpaired t-test). Error bars, S.E.M.
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defective), a gene that encodes a transmembrane channel for dsRNA, required for systemic RNA  interference46. 
To render neurons susceptible to RNAi, a sid-1 transgene is introduced, driven by a pan-neuronal promoter, 
unc-11947. Similarly to the intestine, reduction of smo-1 expression, specifically in neurons, resulted in shorter 
lifespan (Fig. 2D). Importantly, overexpression of smo-1 specifically in the intestine  (pvha-6smo-1), led to an 
extended lifespan (Fig. 2E). On the contrary, neuron-specific smo-1 overexpression  (prab-3smo-1) did not have 
any significant effect on the lifespan of the animals (Fig. 2F). This result suggests the importance of balanced 
SUMO levels in the nervous system. Taken together, these findings indicate that SUMO influences C. elegans 
lifespan through the intestine and the nervous system.
SUMO regulates the transcriptional activity of SKN-1 and DAF-16. To gain insight relevant to the 
role of SUMOylation in the regulation of ageing, we examined the effects of SUMO depletion in the context of 
well-characterized signalling pathways that modulate lifespan in C. elegans5. HSF-1, SKN-1 and DAF-16 are key 
stress response transcription factors, promoting longevity under conditions of heat shock, mild oxidative stress 
and low insulin/IGF1  signalling8. Considering, that HSF-1 has been shown to have the potential to be modified 
by SUMO, both in  mammals48 and in C. elegans49, we focused our studies on SKN-1 and DAF-16. We find that 
skn-1(RNAi);smo-1(RNAi) animals display shorter lifespan, similar to animals subjected only to skn-1 RNAi 
(Fig. 3A). Importantly, SKN-1 depletion annulled lifespan extension caused by SMO-1 overexpression (Fig. 3B). 
Thus, SKN-1 mediates the pro-longevity effects of SUMO. Given that the mammalian orthologue of SKN-1, 
Figure 2.  SUMO modulates lifespan through the intestine and nervous system. (A, B) Knockdown of smo-1 
shortens the lifespan of wild type animals, while overexpression of smo-1 extends lifespan. (C) Intestine specific 
smo-1(RNAi) shortens lifespan. (D) Neuron specific smo-1(RNAi) reduces lifespan. (E) Intestine specific smo-1 
overexpression extends lifespan. (F) Neuron specific smo-1 overexpression does not have a significant effect on 
lifespan. Lifespan assays were carried out at 20 °C. Lifespan values are given in Table S1.
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NRF2 is a target for  SUMOylation50,51, we examined whether SKN-1 is also modified by SUMO conjugation. 
Detection of SUMO modification in vivo poses multiple challenges (low expression of SKN-1 under normal con-
ditions, low SUMOylation rates of total protein content), and we were unable to observe it in our Western blots 
(data not shown). To this end, we performed in vitro SUMOylation assays with bacterially expressed 6xHis-MBP 
tagged and purified SKN-1. We found that SKN-1 is not an optimal SUMO target in vitro (Fig. S2A).
To further investigate the role of SKN-1 in mediating the effects of SUMO on lifespan, we subjected animals 
to oxidative stress which activates SKN-152. We exposed 6 day old wild type, FGP14 and smo-1(RNAi) treated 
animals to 2 mM paraquat, an inducer of oxidative stress. As expected, skn-1(RNAi) treated animals were sensi-
tive to oxidative stress (Fig. 3C). Notably, smo-1 overexpressing animals were resistant to oxidative stress, while 
reduction in smo-1 expression did not alter survival on paraquat (Fig. 3C). We also assayed heat stress resistance 
upon perturbation of SUMO levels. Similarly to oxidative stress, smo-1 overexpression increased survival of 
day 4 animals to acute (2 h) heat shock at 37 °C, whereas, SUMO depletion did not affect heat stress resistance 
(Fig. 3D). Next, we monitored the expression of gst-4, a SKN-1 target gene encoding glutathione S-transferase, 
levels in day 2 animals on 2 mM paraquat. Using a  pgst-4GFP reporter fusion, we found that knockdown of smo-
1 reduced the expression of gst-4, while, overexpression of smo-1 further increased gst-4 expression (Fig. 3E). 
Therefore, under stress conditions, increase of SUMO levels enhances stress resistance by potentiating expression 
of stress response genes, while depletion of SUMO compromises survival under stress by reducing the capacity 
to fully mount a response.
Interestingly, under normal conditions, smo-1 knockdown transiently increased gst-4 expression during 
adulthood in day 4 animals, while there was no observable difference by day 8 (Fig. S2B,C). By contrast, gst-4 
expression was not altered upon smo-1 overexpression during adulthood (day 4 or day 8 animals; Fig. S2B,C). 
The mRNA levels of gst-4 mirrored the changes observed with the  pgst-4GFP reporter fusion (Fig. S2D). We find 
that SKN-1 becomes activated in the absence of the FOXO transcription factor DAF-16 that mediates insulin/
IGF1 signalling, in day 4 of adulthood, both in wild type and smo-1 overexpressing animals (Fig. S2B). SKN-1 
activation is diminished by day 8 (Fig. S2C). Hence, although SKN-1 is likely not modified by SUMO in vivo, 
both are required for normal lifespan. Reduction of SUMO levels triggers activation of SKN-1, while SUMO 
abundance protects against stress and promotes longevity.
In addition to SKN-1, DAF-16 also promotes stress tolerance and  longevity6. We asked whether SUMO exerts 
its effects on animal ageing by modulating DAF-16 activity. DAF-16 is activated in long-lived C. elegans mutants, 
Figure 3.  SKN-1 mediates the lifespan influencing effect of SUMO. (A) smo-1(RNAi) does not further reduce 
the short lifespan of skn-1(RNAi) treated animals. (B) skn-1(RNAi) shortens the lifespan of the FGP14 strain to 
the level seen in wild type animals subjected to skn-1 RNAi. (C) SMO-1 overexpressing animals survive longer 
on 2 mM paraquat, while loss of smo-1 does not change the survival compared to wild type animals. skn-
1(RNAi) treated animals have a reduced survival rate on paraquat. (D) Heat shock did not change the survival of 
smo-1(RNAi) fed animals while worms overexpressing SMO-1 displayed increased survival rates. The percentage 
of animals remaining alive is plotted against age. (E) FGP14 animals are mounting a stronger oxidative stress 
response in day 2 animals compared to control, measured by  pgst-4GFP expression. smo-1(RNAi) reduced the 
responsiveness of animals to paraquat. (n = 40, ***p < 0.001, **p < 0.01 unpaired t-test). Error bars, S.E.M. 
Lifespan assays were carried out at 20 °C. Lifespan values are given in Table S1.
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carrying lesions in the insulin/IGF1 receptor DAF-2. We find that smo-1 knockdown shortened the lifespan of 
DAF-2 deficient animals (Fig. 4A,B). Furthermore, downregulation of daf-16 abolished lifespan extension caused 
by smo-1 overexpression (Fig. 4C). Notably, under lifespan-extending conditions, where DAF-16 is activated (in 
daf-2(e1370) mutants), or protein synthesis is reduced (in ife-2(ok306) mutants), downregulation of the SUMO 
protease ulp-1 extends lifespan (Fig. 4B,D). These findings indicate that DAF-16 is, in part, mediating the effects 
of SUMO on lifespan. Thus, we investigated whether DAF-16 is a target for SUMOylation.
We conducted in vitro SUMOylation assays with purified, bacterially expressed and 6xHis-MBP tagged 
DAF-16. We detected SUMO conjugation to DAF-16 (Fig. 4E top panel, Fig. S3A). To increase the sensitivity 
of our assay, we added fluorescently labelled SUMO (SUMO-AlexaFluor 680)35, which facilitated detection of 
the SUMO-modified form of DAF-16 (Fig. 4E, bottom panel). We also tested the capacity of the MBP tag to 
undergo SUMOylation. We found that MBP is not a SUMO target (Fig. S3B). Therefore, DAF-16 is a bona fide 
SUMOylation target.
Under normal conditions, the activity of DAF-16 is repressed by cytoplasmic confinement and  degradation53. 
To determine whether changes in SUMO levels modulate DAF-16 activity, we monitored the subcellular localiza-
tion of the protein by using a full length  pdaf-16DAF-16::GFP reporter fusion. Downregulation of smo-1 did not 
alter the nuclear/cytoplasm ratio of DAF-16, during adulthood (Fig. 4F). By contrast, smo-1 overexpression trig-
gered nuclear localization of DAF-16, to an extent similar to that observed in DAF-2 deficient animals (Fig. 4F). 
Notably, while SUMO depletion increased daf-16 expression, overexpression of smo-1 reduced daf-16 expression 
(Fig. S3C). Therefore, excess SUMO drives DAF-16 nuclear accumulation. However, subcellular partitioning 
alone is not enough to predict DAF-16  activity54. To gauge the effect of SUMO on the transcriptional activity 
of DAF-16, we assayed the expression of two typical DAF-16 target genes, ges-1 (abnormal gut esterase), a gut 
specific type B carboxylesterase, and sod-3 (superoxide dismutase), an iron/manganese superoxide dismutase. By 
using  pges-1mtGFP and  psod-3GFP reporter fusions, we found that DAF-16 activity increases in day 4 smo-1(RNAi) 
animals (Fig. 4G,H). This increase persists in older animals (day 8 for  pges-1mtGFP and day 6 for  psod-3GFP; 
Fig. S3D,E). Overexpression of smo-1 reduced DAF-16 activity (Fig. 4H,J, Fig. S3E). Notably, knockdown of skn-1 
also activated DAF-16 in both wild type and smo-1 overexpressing animals (Fig. 4G,H, Fig. S3D,E), indicating 
a compensatory link between DAF-16 and SKN-1.
Since SUMOylation has been implicated in chromatin  remodelling55, we considered whether smo-1 over-
expression decreased transcription of DAF-16 target genes by inducing chromatin condensation. We found 
that knockdown of daf-2 increased sod-3 expression in smo-1 overexpressing animals, albeit to a lesser extent, 
compared to wild type controls (Fig. 3H, Fig. S3E). Taken together, these findings indicate that SUMO represses 
the transcriptional activity of DAF-16.
SUMo facilitates mitochondrial homeostasis. Mitochondrial metabolism is an important determi-
nant of ageing across diverse organisms. We found that SUMOylation levels increase not just in whole worm 
lysates (Fig. 1A), but also in the mitochondrial fraction (Fig. S4A). To examine whether SUMO impacts lifes-
pan by altering mitochondrial function, we utilized the dye, TMRE (tetramethylrhodamine, ethyl ester), which 
stains mitochondria according to their membrane potential. Wild type animals display reduced mitochondrial 
membrane potential during  ageing1. Nevertheless, knockdown of smo-1 alleviated age-associated mitochondrial 
membrane potential decline (Fig. 5A,B). Moreover, animals overexpressing smo-1 displayed increased TMRE 
staining early in adulthood (Fig. 5A,B).
Both DAF-16 and SKN-1 are key regulators of the mitochondrial  homeostasis10,56. We find that knockdown of 
smo-1 in genetic backgrounds where DAF-16 is activated, such as isp-1(qm150), skn-1(RNAi), and daf-2(e1370) 
ameliorated mitochondrial membrane potential decline (Fig. S4B,C). Interestingly, mitochondrial membrane 
potential is elevated in DAF-16 deficient animals and does not increase further upon smo-1 downregulation 
(Fig. 5A,B). We also measured mitochondrial ROS production, using the MitoTracker ROS dye. Consistent with 
the TMRE data; smo-1 downregulation altered ROS production in all genetic backgrounds tested, except in DAF-
16 deficient animals (Fig. 5C,D and S4D,E). Overexpression of smo-1 increased ROS production during ageing 
(Fig. 5D). Treatment with the antioxidant NAC (N-acetyl cysteine), diminished the extended lifespan of smo-1 
overexpressing animals (Fig. S4F). Additionally, we utilized the  prpl-17HyPer  strain57 to determine  H2O2 levels in 
animals treated with RNAi against smo-1. Similarly to MitoTracker ROS staining, aged (8-day old) smo-1 depleted 
animals exhibited higher  H2O2 levels compared to control (Fig. 5E). Together, these findings suggest that SUMO 
Figure 4.  DAF-16 is SUMO modified and SUMO inhibits the transcriptional activity of DAF-16. (A) smo-
1(RNAi) shortens the lifespan of daf-16(mu86) animals. (B) The long lifespan of daf-2(e1370) animals is 
reduced by smo-1(RNAi) and extended by ulp-1(RNAi). (C) daf-16(RNAi) partly shortens the long lifespan of 
FGP14 strain. (D) ife-2(ok306) animals treated with ulp-1 RNAi have a longer lifespan. (E) In vitro DAF-16 
SUMOylation assay. Top image shows Coomassie staining, bottom image shows fluorescently labelled SUMO 
with Alexa-Fluor 680. Brackets indicate the SUMO modified form of DAF-16. (F) Nuclear localization of 
 pdaf-16DAF-16::GFP in control, smo-1(RNAi) and smo-1 overexpressing background (FGP14), daf-2(RNAi) was 
used as a positive control, scale bar: 50 μm. Images were acquired using × 40 objective lens (n = 50, ***p < 0.001, 
unpaired t-test). (G)  pges-1mtGFP expression is elevated upon smo-1(RNAi) in wild type, daf-2(RNAi) and 
skn-1(RNAi) background in day 4 animals (n = 100, **p < 0.01, ***p < 0.001, unpaired t-test). (H)  psod-3GFP is 
increased upon knockdown of smo-1, skn-1 or daf-2. Overexpression of smo-1 reduces the expression level of 
 psod-3GFP in day 4 animals (n = 100, *p < 0.05, ***p < 0.001, unpaired t-test). (I, J). The mRNA levels of sod-3 and 
ges-1 are reduced in day 4 animals in the smo-1 overexpressing strain (***p < 0.001, unpaired t-test). Error bars, 
S.E.M. Lifespan assays were carried out at 20 °C. Lifespan values are given in Table S1.
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represses mitochondrial activity during ageing via DAF-16. As readouts of mitochondrial function, we measured 
production of ATP and oxygen consumption rates in 4-day old animals. We did not detect significant change 
upon smo-1(RNAi) in wild type or daf-16(-) genetic background (Fig. S5A,B). daf-2(e1370) animals displayed 
lower oxygen consumption rates, and smo-1(RNAi) did not significantly alter this rate (Fig. S5B). On the contrary, 
knockdown of smo-1 resulted in higher ATP production in day 6 wild type animals (Fig. 5F), consistent with the 
TMRE and MitoTracker ROS staining results (Fig. 5A–D). Intriguingly, SMO-1 depletion reduced ATP levels in 
daf-2(e1370) and daf-16(mu86) animals (Fig. 5F), indicating that mitochondrial ROS and ATP production are 
uncoupled in these genetic backgrounds. To assay mitochondrial content, we used two methods: paraquat (4 mM) 
treatment followed by TMRE staining and mitochondrial DNA copy number measurement. Administration of 
paraquat leads to mitochondrial membrane potential dissipation; therefore, accumulation of TMRE reflects the 
number of mitochondria. Interestingly, downregulation of smo-1 increased the number of mitochondria during 
ageing in a DAF-16 dependent manner (Fig. S5C,D); but not mitochondrial DNA copy number (Fig. S5E,F). 
Thus, mitochondrial function and mass are upregulated upon smo-1 knockdown during ageing.
Alongside changes in mitochondrial activity, morphological alterations occur during ageing. The intercon-
nected, tubular mitochondrial network in young animals becomes fragmented as they  age9,10. We followed mito-
chondrial morphology during ageing using a mitochondrially localized  pges-1mtGFP reporter fusion (Fig. 6A). The 
mitochondrial network displayed extended fragmentation by day 8 of adulthood in wild type, but not in SMO-1 
depleted animals (Fig. 6A), indicating a requirement for SUMO for mitochondrial fission. DAF-16 has been 
implicated in the regulation of mitochondrial  morphology10. We examined whether SMO-1 modulates mito-
chondrial morphology through DAF-16. Knockdown of daf-16 caused mitochondrial network fragmentation 
in SMO-1 deficient animals, during ageing (Fig. 6A). DAF-16 controls the expression of eat-3 (eating: abnormal 
pharyngeal pumping), a gene encoding the homologue of OPA1, a protein required for the fusion of inner mito-
chondrial  membrane58,59. EAT-3 deficient animals display a fragile, fragmented intestinal mitochondrial network. 
Similarly to DAF-16, we find that downregulation of eat-3 triggered mitochondrial network fragmentation in 
Figure 5.  SUMO changes the mitochondrial homeostasis. (A, B) TMRE staining declines during ageing 
in wild type but not smo-1(RNAi) treated animals, and this change is DAF-16 dependent (n = 100, *p < 0.05, 
**p < 0.01, ***p < 0.001, unpaired t-test). (C, D) Mitochondrial ROS production, measured by MitoTracker ROS, 
is increased when we knockdown smo-1 and this effect is also DAF-16 dependent (n = 75, *p < 0.05, **p < 0.01, 
***p < 0.001, unpaired t-test). (E)  H2O2 levels are increased in smo-1(RNAi) background, measured by the  H2O2 
biosensor, HyPer (n = 30, **p < 0.01, unpaired t-test). (F) ATP production is increased upon knockdown of smo-
1 in day 6 wild type animals (*p < 0.05, ***p < 0.001, unpaired t-test). Error bars, S.E.M.
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SMO-1 deficient animals, during ageing (Fig. 6A). These findings indicate that SMO-1 modulates the morphol-
ogy of mitochondria via DAF-16.
In addition to EAT-3/OPA-1, DRP-1 (dynamin related protein-1) and FZO-1 (Fzo mitochondrial fusion 
protein related), regulate mitochondrial network remodelling. Notably, DRP1 becomes SUMOylated in mitosis, 
cell death and  ischemia60–63. In C. elegans, reduced expression of drp-1 or fzo-1 leads to mitochondrial network 
 fragmentation10 (Fig. 6B). We find that smo-1 knockdown partially restores mitochondrial network connectivity 
upon drp-1 and fzo-1 downregulation (Fig. 6B). Combined, our observations suggest that SUMO is required for 
mitochondrial fission and exerts its effect on the mitochondrial fusion/fission machinery via DAF-16.
Previous studies have shown that mitochondrial fission is required for, and precedes  mitophagy64. Since 
SUMO impinges on mitochondrial dynamics, we tested whether mitophagy is also affected upon downregulation 
of smo-1 expression. To monitor mitophagy, we used a mitochondria targeted, ratiometric Rosella biosensor, 
expressed in body wall muscle  cells10. Under mitophagy-inducing, low insulin/IGF1 signalling conditions, in 
daf-2 mutants, the ratio of GFP/DsRed fluorescence is reduced, signifying mitophagy induction (Fig. 6C, S6A). 
By contrast, knockdown of smo-1 increased the GFP/DsRed ratio, indicating that SUMO depletion inhibits 
Figure 6.  SUMO is required for efficient mitochondrial fission and regulates mitophagy. (A) The intestinal 
mitochondrial network becomes fragmented in day 8 wild type animals, but remains interconnected in smo-
1(RNAi) treated animals, and the mitochondrial network influencing effect of SMO-1 is DAF-16 and EAT-3 
dependent, scale bar: 10 μm. Images were acquired using × 63 objective lens (n = 40). (B) In the absence of drp-1 
or fzo-1 the mitochondrial network undergoes fragmentation, and the loss of smo-1 rescues this phenotype 
(n = 15). (C) daf-2(RNAi) increases, while smo-1(RNAi) inhibits mitophagy in muscle cells (n = 40, **p < 0.01, 
***p < 0.001, unpaired t-test). (D) Depletion of smo-1 induces neuronal mitophagy (n = 20, **p < 0.01, unpaired 
t-test). Error bars, S.E.M.
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mitophagy (Fig. 6C, S6A). This observation is consistent with the block of mitochondrial fission upon smo-1 
downregulation (Fig. 6B). Additionally, we also assayed mitophagy in the nervous  system65, in the RNAi sensi-
tive, rrf-3(pk1426) mutant background. Surprisingly, reduced smo-1 expression resulted in the induction of 
mitophagy in neurons (Fig. 6D, S6B). Thus, SUMO is required to perform mitochondrial fission and mitophagy 
in a tissue specific manner.
Discussion
The regulatory role of SUMO in the ageing process remains elusive, up to date. Earlier studies in mice uncov-
ered a progressive increase of protein SUMOylation in brain and plasma, during  ageing29. Notably, we find a 
similar increase in the amount of SUMO, during adulthood in C. elegans, both in whole worm lysates and in the 
mitochondrial fraction (Fig. 1A, S4A). Interestingly, reducing the expression of SUMO proteases did not have 
any lifespan altering effect under normal conditions (Fig. S1B,C). Presumably, the function of these proteases 
is redundant. Furthermore, under various stress conditions mild heat stress (25 °C), reduced translational rates 
(ife-2(-) mutant background) and low insulin signalling (daf-2(-) mutant background) the loss of ulp-1 resulted 
in an extended lifespan (Figs. S1D, 4B,D). Therefore, specific SUMO proteases have the potential to regulate 
longevity upon stress conditions. To define the exact role of each SUMO protease under distinct stress insults 
is an interesting topic for future investigations. SMO-1 is expressed in all animal tissues and mainly localizes to 
the  nucleus66. Accordingly, the most studied functions of SUMO are nucleus-associated14,67,68; however, its role 
outside of the nucleus is  emerging69, with a focus on the nervous system. Indeed, we find that tightly controlled 
expression level of smo-1 is a prerequisite for normal lifespan (Fig. 2). A recent study implicated SUMOylation 
of the germline RNA binding protein CAR-1 (cytokinesis, apoptosis, RNA-associated), in the regulation of lifes-
pan by insulin signalling. Under low insulin signalling conditions (in daf-2 mutants), CAR-1 is less likely to be 
SUMO-modified, and can effectively inhibit glp-1 expression in the germline, allowing for lifespan  extension28. 
Our findings indicate that DAF-16 and SKN-1 mediate the effects of SUMO on ageing, in the soma.
SUMOylation of transcription factors is mostly coupled with transcriptional  repression70. Indeed, we found 
that DAF-16 is a target for SUMOylation, upon which, its transcriptional activity is quenched (Fig. 4). Under 
basal conditions this modification could serve to inhibit the unnecessary activation of stress response genes by 
nuclear localized DAF-16. Indeed, SUMO overexpression leads to the nuclear accumulation of DAF-16 (Fig. 4F); 
however, without the activation of DAF-16 target genes (Fig. 4G–J). Consequently, the long lifespan of SUMO 
overexpressing animals is only marginally shortened upon daf-16 knockdown (Fig. 4C). On the other hand, 
reduced skn-1 expression in the SUMO overexpressing background completely abolished lifespan extension in 
SUMO overexpressing animals (Fig. 3B). These results indicate that the interplay between DAF-16 and SKN-1 
is an important determinant of the ageing mechanism. Notably, numerous pathways converge on organismal 
 lifespan71; further studies could determine the DAF-16 independent, lifespan extending mechanisms upon 
SMO-1 overexpression in C. elegans. Removal of SUMO results in the upregulation of stress responsive genes, 
controlled by DAF-16 and SKN-1 (Figs. 4G–J, S2B,D). These findings are consistent with the reported functions 
of SUMOylation in the regulation of stress responses (e.g. DNA damage response, ER stress, heat shock), which 
are indispensable for cellular  survival72. Furthermore, a recent study indicates that activation of SKN-1 nega-
tively regulates DAF-16, which is in agreement with our data showing the increased expression of DAF-16 target 
genes upon skn-1(RNAi)73 (Fig. 4G,H). It would be interesting to analyse the role of SUMO in this interaction. 
Our results hint towards the possibility of the requirement of SUMO modification of DAF-16 for the successful 
SKN-1 repression. Thus, SUMO depletion compromises cellular homeostasis, and may, additionally, generate a 
state of cellular stress that contributes to early organismal death (Fig. 7).
SUMOylation has also been linked to mRNA translation  regulation74, and chromatin  organization55. Notably, 
hyposumoylation of chromatin has been associated with pluripotency reprogramming and enhanced lineage 
trans-differentiation75. We considered whether the changes in transgene expression upon SUMO depletion, or 
overexpression, in C. elegans are an indirect consequence of alterations in chromatin structure, and/or mRNA 
translation. We observed that downregulation of daf-2 is sufficient to restore expression of sod-3, a DAF-16 target 
gene, which is significantly reduced upon SUMO overexpression (Fig. 4H), indicating that the chromatin is still 
accessible under this condition. Furthermore, expression of gst-4, a SKN-1 target gene, is not affected by SUMO 
overexpression (Fig. S2B–D) and increases following paraquat treatment (Fig. 3E). By contrast, SUMO deficiency 
results in the upregulation of both sod-3, and gst-4 expression (Figs. 4H, S2B). Therefore, loss of SUMO engages 
stress response pathways, involving both DAF-16 and SKN-1 transcription factors (Fig. 7).
SUMOylation has been linked to mitochondrial biogenesis and network remodelling through PGC-1α and 
Drp1 in  mammals63,76,77. Moreover, SUMO modification of ATFS-1 and DVE-1 play a regulatory role in the 
process of mitochondrial unfolded protein response (mtUPR)78. Here, we examined the involvement of SUMO 
in mitochondrial homeostasis. We observed an increase in mitochondrial content, but not in mitochondrial 
DNA copy number upon depletion of SUMO in C. elegans (Fig. S5C–F). Additionally, ATP and ROS produc-
tion increases in aged animals, indicating elevated mitochondrial activity (Fig. 5C–F). Moreover, we found that 
SUMO promotes mitochondrial fragmentation during ageing (Fig. 6A,B) and it is also required for mitochondrial 
turnover via mitophagy in muscle cells (Fig. 6C). Intriguingly, SUMO blocks the process of mitophagy in the 
nervous system (Fig. 6D). Admittedly, increased mitophagy has been shown to have detrimental consequences 
on the homeostasis of the  cell79,80. The tissue specific effects of SUMO on mitophagy merits further research. 
Notably, while in long-lived mutants, mitochondria display elongated morphology, coupled with reduced ROS 
 production58, we find that short-lived, SUMO-depleted animals also feature elongated mitochondrial network, 
but elevated generation of ROS. This discrepancy indicates that mitochondrial turnover is differentially affected 
in long-lived, and short-lived, SUMO deficient mutants. In long-lived animals a healthy interconnected mito-
chondrial network is maintained by increased mitophagy, which moderates ROS  production10. Instead, SMO-1 
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knockdown interferes with mitochondrial fission and fusion, which in turn impairs mitophagy, resulting in accu-
mulation of mitochondrial damage, higher ROS levels, and shorter lifespan. Our observations suggest that SUMO 
decreases mitochondrial function and promotes mitochondrial fission during ageing in C. elegans (Fig. 7). These 
findings are consistent with recent studies suggesting that impairment of mitochondrial dynamics contributes 
to the decline of mitochondrial function during ageing and the onset of age-related  diseases81.
Collectively, our findings indicate that SUMO influences the ageing process by modulating the transcriptional 
activity of the stress response transcription factors, DAF-16 and SKN-1 (Fig. 7). Admittedly, these are not the 
only transcription factors that could be affected by the depletion of SUMO. Further research is required to fully 
map the molecular changes in response to altered SUMO levels. Notably, recent studies have implicated SUMO 
in senescent decline. SUMOylation of p53 causes cellular  senescence82, while deSUMOylation of Bmi1, a poly-
comb repressive complex member, is likewise, required for  senescence83. Moreover, the SUMO E2 enzyme, Ubc9, 
regulates senescence by relocation of SUMOylated proteins to PML nuclear  bodies84. Thus balanced protein 
SUMOylation is critical for stress resistance and survival. The ageing process disrupts SUMOylation balance 
while manipulations that fine-tune protein SUMOylation promote longevity.
Here, we demonstrate that the abundance of SUMO regulates lifespan. Reduced SUMO levels shorten lifes-
pan, while increased smo-1 expression results in extended lifespan (Figs. 2, 7). SUMO influences ageing mainly 
through DAF-16 and SKN-1 (Figs. 3A,B, 4A,B), in a tissue specific manner, through the intestine and the nervous 
system (Fig. 2). We further show that DAF-16 is a target for SUMOylation, and that SUMO attachment represses 
the transcriptional activity of DAF-16 (Figs. 4, 7). We propose that under normal conditions, modification of 
DAF-16 by SUMO could prevent uncontrolled activation of nuclearly localized DAF-16 (Fig. 7). Accordingly, 
overabundance of SUMO leads to strong DAF-16 inhibition (Fig. 4H–J). Nonetheless, SUMO overexpressing 
animals exhibit long lifespan, which is dependent on SKN-1 (Fig. 3B) and in a lesser extent on DAF-16 (Fig. 4C). 
In addition, SUMO plays a critical role in the maintenance of mitochondrial homeostasis. Altering SUMO lev-
els affects mitochondrial ATP and ROS production (Fig. 5), as well as, mitochondrial dynamics and clearance 
(Figs. 6, 7). Combined, our findings indicate that balanced protein SUMOylation is a prerequisite for healthy 
animal ageing.
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